| 7.67 0.19 (2.54%) | 01-30 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 8.97 |
1-year : | 10.47 |
| Resists | First : | 7.67 |
Second : | 8.97 |
| Pivot price | 7.39 |
|||
| Supports | First : | 7.32 |
Second : | 7.11 |
| MAs | MA(5) : | 7.48 |
MA(20) : | 7.35 |
| MA(100) : | 6.93 |
MA(250) : | 6.98  |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 73.3 |
D(3) : | 64.8 |
| RSI | RSI(14): 63 |
|||
| 52-week | High : | 8.42 | Low : | 5.92 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ VMD ] has closed Bollinger Bands are 23.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 7.69 - 7.72 | 7.72 - 7.74 |
| Low: | 7.34 - 7.38 | 7.38 - 7.41 |
| Close: | 7.62 - 7.67 | 7.67 - 7.72 |
Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment (DME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company also leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), percussion vests, oxygen concentrator units, and other small respiratory equipment; and sells and rents DME and patient medical services. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management related solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
Sun, 01 Feb 2026
When Should You Buy Viemed Healthcare, Inc. (NASDAQ:VMD)? - Yahoo Finance
Fri, 30 Jan 2026
Viemed Healthcare: Remaining Bullish On Keen Valuation And Buoyant Cash Flow - Seeking Alpha
Thu, 29 Jan 2026
Viemed Healthcare, Inc. (VMD) Stock Analysis: A Promising 76% Upside Potential for Investors - DirectorsTalk Interviews
Thu, 15 Jan 2026
Viemed Healthcare, Inc. (NASDAQ:VMD) is favoured by institutional owners who hold 58% of the company - Yahoo Finance
Sat, 10 Jan 2026
Viemed Healthcare (NASDAQ:VMD) Stock Rating Upgraded by Zacks Research - MarketBeat
Tue, 06 Jan 2026
Stonegate Capital Partners Initiates Coverage on Viemed Healthcare, Inc. (VMD) - Nasdaq
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 38 (M) |
| Shares Float | 30 (M) |
| Held by Insiders | 13.5 (%) |
| Held by Institutions | 66.9 (%) |
| Shares Short | 325 (K) |
| Shares Short P.Month | 394 (K) |
| EPS | 0.34 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 3.5 |
| Profit Margin | 5.3 % |
| Operating Margin | 9.6 % |
| Return on Assets (ttm) | 6.4 % |
| Return on Equity (ttm) | 10.6 % |
| Qtrly Rev. Growth | 24 % |
| Gross Profit (p.s.) | 3.87 |
| Sales Per Share | 6.7 |
| EBITDA (p.s.) | 1.22 |
| Qtrly Earnings Growth | -9.9 % |
| Operating Cash Flow | 48 (M) |
| Levered Free Cash Flow | 10 (M) |
| PE Ratio | 22.55 |
| PEG Ratio | 0 |
| Price to Book value | 2.18 |
| Price to Sales | 1.14 |
| Price to Cash Flow | 6.01 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|